News GlycoMimetics, Inc.

Equities

GLYC

US38000Q1022

Real-time Estimate Cboe BZX Other stock markets 03:00:01 2024-04-16 pm EDT			5-day change	1st Jan Change
2.22 ^USD	-1.55%		-18.28%	-7.20%

Mar. 27	Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024
Mar. 27	GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024	Mar. 27
GlycoMimetics: Q4 Earnings Snapshot	Mar. 27	AQ
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023	Mar. 27	BU
GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
GlycoMimetics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 27	CI
North American Morning Briefing : Stocks Edge -2-	Mar. 27	DJ
GlycoMimetics to Report Fourth Quarter and 2023 Full Year Financial Results on March 27, 2024	Mar. 13	BU
GlycoMimetics to Participate in Upcoming Cowen 44th Annual Health Care Conference	Feb. 26	BU
GlycoMimetics Reports Inducement Grant under NASDAQ Listing Rule 5635(4)	Feb. 13	AQ
GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	Feb. 12	BU
GlycoMimetics, Inc. Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1A Healthy Volunteer Study of GMI-1687	Jan. 04	CI
GlycoMimetics Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1a Healthy Volunteer Study of GMI-1687	Jan. 04	BU
Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia	Jan. 03	AQ
GlycoMimetics, Thermo Fisher Unit Set Accord for Manufacturing Uproleselan for Acute Myeloid Leukemia	Jan. 02	MT
Capital One Initiates GlycoMimetics With Overweight Rating, Price Target is $12	Dec. 22	MT
GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia	Dec. 10	BU
GlycoMimetics to Participate in Upcoming Jefferies London Healthcare Conference	Nov. 09	BU
GlycoMimetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 03	CI
Transcript : GlycoMimetics, Inc., Q3 2023 Earnings Call, Nov 03, 2023	Nov. 03
GlycoMimetics: Q3 Earnings Snapshot	Nov. 03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News GlycoMimetics, Inc.

Equities

GLYC

US38000Q1022

Summary

Filters